SCHEMBL16446138

SCHEMBL16446138

CS(=O)(=O)NC(=O)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
HDAC8 Q9BY41 1/20 0.57
HDAC6 Q9UBN7 1/20 0.57
EPHX2 P34913 1/20 0.53
EGFR P00533 5/20 0.53
ERBB2 P04626 5/20 0.53
PRMT1 Q99873 1/20 0.51
CXCL8 P10145 1/20 0.50
HPGD P15428 1/20 0.50
CA12 O43570 2/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA5A P35218 2/20 0.49
CA7 P43166 2/20 0.49
CA9 Q16790 2/20 0.49
CA5B Q9Y2D0 2/20 0.49
CA14 Q9ULX7 1/20 0.49
ALDH1A1 P00352 1/20 0.49
CNR2 P34972 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31023859 0.83 LMNA (0.51) EGFRERBB2CA2
SCHEMBL10405410 0.82 MEN1 (0.59) MEN1KMT2AHDAC8HDAC6EPHX2
SCHEMBL23733121 0.81 HDAC2 (0.59) MEN1KMT2AHDAC8HDAC6HPGD
SCHEMBL21887555 0.81 PDE4B (0.46) EGFRERBB2CXCL8ALDH1A1CNR2
SCHEMBL17127746 0.81 EGFR (0.68) MEN1KMT2AEGFRERBB2
SCHEMBL16905382 0.81 EGFR (0.53) MEN1KMT2AEGFRERBB2ALDH1A1
SCHEMBL27796626 0.81 CA1 (0.57) MEN1KMT2AHDAC8HDAC6EPHX2
SCHEMBL13946581 0.79 MEN1 (0.50) MEN1KMT2AHDAC8HDAC6EPHX2
SCHEMBL7697158 0.79 EGFR (0.67) MEN1KMT2AEPHX2EGFRERBB2
Phenylacetic Acid SCHEMBL23925805 0.78 AKR1B1 (0.74) MEN1KMT2AHDAC8HDAC6EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230359119-A1 RESIST COMPOSITION AND PATTERN FORMING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-11-09 US disclosed
WO-2015019347-A1 GIRK AS A THERAPEUTIC TARGET OF IMMUNE DISORDERS AND A MARKER OF B CELL SUBTYPES YEDA RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) 2015-02-12 WO disclosed
CN-1318541-A Sulfonyl-containing pyrrolidone compound and preparation method and pharmaceutical application thereof INST OF PHARMACOLOGY CHINESE A (CN) 2001-10-24 CN disclosed